Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 323 (E.D.Tex. Apr. 27, 2017)
Cite Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 323 (E.D.Tex. Apr. 27, 2017)
+ More Snippets
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 313 (E.D.Tex. Apr. 10, 2017)
Cite Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 313 (E.D.Tex. Apr. 10, 2017)
+ More Snippets
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 284 (E.D.Tex. Feb. 28, 2017)
Cite Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 284 (E.D.Tex. Feb. 28, 2017)
+ More Snippets
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 265 (E.D.Tex. Jan. 26, 2017)
Cite Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 265 (E.D.Tex. Jan. 26, 2017)
+ More Snippets
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 252 (E.D.Tex. Jan. 12, 2017)
Cite Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 252 (E.D.Tex. Jan. 12, 2017)
+ More Snippets
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 250 (E.D.Tex. Jan. 12, 2017)
Cite Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 250 (E.D.Tex. Jan. 12, 2017)
+ More Snippets
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 251 (E.D.Tex. Jan. 12, 2017)
Cite Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 251 (E.D.Tex. Jan. 12, 2017)
+ More Snippets
Document
IPR2016-01130, No. 147 Order - Canceling Oral Aargument (P.T.A.B. Jan. 7, 2019)
Cite Document
IPR2016-01130, No. 147 Order - Canceling Oral Aargument (P.T.A.B. Jan. 7, 2019)
+ More Snippets
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 214 (E.D.Tex. Dec. 13, 2016)
Cite Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 214 (E.D.Tex. Dec. 13, 2016)
+ More Snippets
Document
IPR2016-01130, No. 141 Order - ORDER Denying Request for Authorization to File Motion to Stay37 CFR 425 (P.T.A.B. Dec. 20, 2018)
Cite Document
IPR2016-01130, No. 141 Order - ORDER Denying Request for Authorization to File Motion to Stay37 CFR 425 (P.T.A.B. Dec. 20, 2018)
+ More Snippets
Document
IPR2016-01130, No. 141 Order - ORDER Denying Request for Authorization to File Motion to Stay37 CFR ¿¿ 425 (P.T.A.B. Dec. 20, 2018)
Cite Document
IPR2016-01130, No. 141 Order - ORDER Denying Request for Authorization to File Motion to Stay37 CFR ¿¿ 425 (P.T.A.B. Dec. 20, 2018)
+ More Snippets
Document
IPR2016-01130, No. 139 Order - Rescheduling the Date for Oral ArgumentAuthorizing Supplemental Briefing37 CFR 425 (P.T.A.B. Nov. 30, 2018)
Cite Document
IPR2016-01130, No. 139 Order - Rescheduling the Date for Oral ArgumentAuthorizing Supplemental Briefing37 CFR 425 (P.T.A.B. Nov. 30, 2018)
+ More Snippets
Document
IPR2016-01130, No. 139 Order - Rescheduling the Date for Oral ArgumentAuthorizing Supplemental Briefing37 CFR § 425 (P.T.A.B. Nov. 30, 2018)
Cite Document
IPR2016-01130, No. 139 Order - Rescheduling the Date for Oral ArgumentAuthorizing Supplemental Briefing37 CFR § 425 (P.T.A.B. Nov. 30, 2018)
+ More Snippets
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 551 (E.D.Tex. Nov. 13, 2018)
Cite Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 551 (E.D.Tex. Nov. 13, 2018)
+ More Snippets
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 546 (E.D.Tex. Nov. 20, 2017)
Cite Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 546 (E.D.Tex. Nov. 20, 2017)
+ More Snippets